This study focuses on elucidating key signaling proteins in alternative signaling pathways which result in EGFR/c-Met TKI resistance in lung cancer cell lines which have wild type EGFR or EGFR with T790M mutation. This evidence concerns the gene EGFR and lung carcinoma.